Gabriel K. Bell > Latham & Watkins LLP > Washington DC, United States > Lawyer Profile
Latham & Watkins LLP Offices

555 ELEVENTH STREET, NW, SUITE 1000
WASHINGTON DC 20004-1304
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Gabriel K. Bell

Position
Gabriel Bell is head of the firm’s Intellectual Property Appellate Practice and is regarded as one of the nation’s top IP appellate litigators. He represents market-leading technology and life sciences companies in the Federal Circuit and district courts. He is Chambers-ranked in IP Appellate and was recognized as the IP Appellate Litigator of the Year by LMG Life Sciences.
Gabriel combines his sophisticated technical knowledge with extensive experience in the Federal Circuit and federal district courts to guide clients across a broad range of sectors, including:
-
- Computer
- Telecommunication
- Pharmaceutical
- Biotech
- Automotive
- Financial
He has argued over 20 Federal Circuit appeals and has led and briefed dozens of others. He also routinely argues and briefs dispositive motions in district courts. He has particular expertise in patent eligibility under Section 101 of the Patent Act.
Gabriel serves as Co-Chair of the Federal Circuit Bar Association’s Scholarship Committee and maintains an active pro bono practice, including representing veterans in appeals.
Before joining Latham, Gabriel was counsel for the US Senate Committee on the Judiciary. He has also held positions at the US Department of Justice and NASA Langley Research Center. In addition, he clerked for judges on the D.C. and Fifth Circuits.
Gabriel is admitted to practice in the Supreme Court and the Fifth, Ninth, D.C., and Federal Circuits.
Career
https://www.lw.com/people/gabriel-bell
Lawyer Rankings
United States > Intellectual property > Patents: litigation (full coverage)
(Leading partners)Recognised for its ‘strong track record of great results’, Latham & Watkins LLP’s team advises household names on complex, multi-patent and high-value patent litigation cases. As well as its market-leading pharmaceutical and life sciences patent practice, the ‘extremely sharp’ department has been growing a major technology offering for technology giants such as Netflix and Taiwan Semiconductor Manufacturing Corporation. The team demonstrates experience in all key litigation avenues, including the ITC and PTAB. David P. Frazier, from Washington DC, is a stand-out practitioner renowned for defending cutting-edge pharmaceutical products against infringing biosimilars. Frazier co-heads the department with Jennifer Barry, based in San Diego, and Austin’s Jeff Homrig. In Washington, DC, Gabriel K. Bell specializes in patent litigation in the Federal Circuit and District Courts. In New York City, Rachel Renee Blitzer, who was promoted to partnership in March 2024, focuses on complex patent and trade secret cases involving technologies, machinery, and medical devices. Douglas Lumish
is well-regarded for his exceptional patent litigation record, and practices from the Bay Area. Maximilian Grant retired in December 2024.
Lawyer Rankings
- Leading partners United States > Intellectual property > Patents: litigation (full coverage)
- Patents: litigation (full coverage) United States > Intellectual property
Top Tier Firm Rankings
- Insurance > Advice to policyholders
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Cartel
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Finance > Commercial lending: Advice to bank lenders
- Intellectual property > Copyright
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Real estate > Land use/zoning
- Intellectual property > Patents: licensing
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Antitrust > Merger control
- International trade and national security > National Security
- Intellectual property > Patents: licensing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Industry focus > Sport
- Finance > Structured finance: derivatives and structured products
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- M&A/corporate and commercial > Corporate governance
- International trade and national security > Customs, export controls and economic sanctions
- Industry focus > Education
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Government > Government contracts
- Insurance > Insurance: non-contentious
- Dispute resolution > International litigation
- Dispute resolution > Leading trial lawyers
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Financial services litigation
- Healthcare > Health insurers
- Media, technology and telecoms > Outsourcing
- Healthcare > Service providers
- Dispute resolution > International arbitration
- Dispute resolution > Leading trial lawyers
- Intellectual property > Trademarks: litigation
- Dispute resolution > Leading trial lawyers
- Finance > Financial services regulation
- Finance > Commercial lending > Advice to direct lenders/private credit
- Dispute resolution > Corporate investigations and white-collar criminal defense